2017-2021 UK Sexually-Transmitted Diseases (STD) Market: Emerging Opportunities and Growth Strategies for Suppliers
About This Report
This new 280-page report from VPGMarketResearch.com presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.
In addition to market share and sales forecasts, the report:
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.
Contains 280 pages and 16 tables
This new 280-page report from VPGMarketResearch.com presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies
- Reviews features and operating characteristics of major analyzers used for STD testing
- Profiles key suppliers and potential market entrants developing innovative technologies and products
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.
Contains 280 pages and 16 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Therapeutic Drug Monitoring Tests
1. O5ER6EW
2. CARBAMAZEP1NE
3. CYCLOSPOR1N
4. D1GO11N
5. E5EROL1MUS
6. GENTAM1C1N
7. LAMOTR1G1NE/LAM1CTAL
8. LE5ET1RACETAM
9. L1DOCA1NE
10. L1TH1UM
11. PHENYTO1N
12. NAPA/PROCA1NAM1DE
13. QU1N1D1NE
14. S1ROL1MUS
15. TACROL1MUS
16. TOP1R1MATE
17. THEOPHYLL1NE
18. 5ALPRO1C AC1D
B. 1nstrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/1nverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, 5ital Diagnostics and other suppliers
C. Major 1n 5itro Diagnostic Technologies And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
2. 1MMUNOASSAYS
a. Technological Principle
d. Chemiluminescence
c. Enzyme 1mmunoassays (E1A)
Overview
EL1SA
EM1T
Electrochemical
d. Radioimmunoassays (R1A)
e. 1mmunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. 1T AND AUTOMAT1ON
5. DRY CHEM1STRY
6. B1OSENSORS
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKET1NG APPROACHES
2. PRODUCT COMPLE11TY
3. CUSTOMER PREFERENCE
4. ESTABL1SHED SUPPL1ERS
5. EMERG1NG SUPPL1ERS
6. MAJOR TYPES OF D1STR1BUTORS
7. MARKET SEGMENTAT1ON
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
*UL1RO5
1nstrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
L1ST OF TABLES
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing 5alproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
U.K., Laboratories Performing TDM Tests By Market Segment
U.K., Hospital Laboratories Performing TDM Tests By Bed Size
U.K., Commercial/Private Laboratories Performing TDM Tests By Annual Test 5olume
U.K., TDM Test 5olume Forecast By Market Segment
U.K., Hospital Laboratories, TDM Test 5olume Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Test 5olume Forecast by Assay
U.K., TDM Reagent Market Forecast By Market Segment
U.K., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.K., Major Suppliers of 1mmunodiagnostic Products, Estimated Market Shares
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Therapeutic Drug Monitoring Tests
1. O5ER6EW
2. CARBAMAZEP1NE
3. CYCLOSPOR1N
4. D1GO11N
5. E5EROL1MUS
6. GENTAM1C1N
7. LAMOTR1G1NE/LAM1CTAL
8. LE5ET1RACETAM
9. L1DOCA1NE
10. L1TH1UM
11. PHENYTO1N
12. NAPA/PROCA1NAM1DE
13. QU1N1D1NE
14. S1ROL1MUS
15. TACROL1MUS
16. TOP1R1MATE
17. THEOPHYLL1NE
18. 5ALPRO1C AC1D
B. 1nstrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/1nverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, 5ital Diagnostics and other suppliers
C. Major 1n 5itro Diagnostic Technologies And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
2. 1MMUNOASSAYS
a. Technological Principle
d. Chemiluminescence
c. Enzyme 1mmunoassays (E1A)
Overview
EL1SA
EM1T
Electrochemical
d. Radioimmunoassays (R1A)
e. 1mmunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. 1T AND AUTOMAT1ON
5. DRY CHEM1STRY
6. B1OSENSORS
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKET1NG APPROACHES
2. PRODUCT COMPLE11TY
3. CUSTOMER PREFERENCE
4. ESTABL1SHED SUPPL1ERS
5. EMERG1NG SUPPL1ERS
6. MAJOR TYPES OF D1STR1BUTORS
7. MARKET SEGMENTAT1ON
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
*UL1RO5
1nstrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
L1ST OF TABLES
Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing 5alproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
U.K., Laboratories Performing TDM Tests By Market Segment
U.K., Hospital Laboratories Performing TDM Tests By Bed Size
U.K., Commercial/Private Laboratories Performing TDM Tests By Annual Test 5olume
U.K., TDM Test 5olume Forecast By Market Segment
U.K., Hospital Laboratories, TDM Test 5olume Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Test 5olume Forecast by Assay
U.K., TDM Reagent Market Forecast By Market Segment
U.K., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.K., Major Suppliers of 1mmunodiagnostic Products, Estimated Market Shares